145 related articles for article (PubMed ID: 28540403)
1. Analysis of primary-miRNA-3662 and its mature form may improve detection of the lung adenocarcinoma.
Powrózek T; Mlak R; Dziedzic M; Małecka-Massalska T; Sagan D
J Cancer Res Clin Oncol; 2017 Oct; 143(10):1941-1946. PubMed ID: 28540403
[TBL] [Abstract][Full Text] [Related]
2. Investigation of relationship between precursor of miRNA-944 and its mature form in lung squamous-cell carcinoma - the diagnostic value.
Powrózek T; Mlak R; Dziedzic M; Małecka-Massalska T; Sagan D
Pathol Res Pract; 2018 Mar; 214(3):368-373. PubMed ID: 29496309
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic role of plasma circulating precursors of miRNA-944 and miRNA-3662 for non-small cell lung cancer detection.
Powrózek T; Kuźnar-Kamińska B; Dziedzic M; Mlak R; Batura-Gabryel H; Sagan D; Krawczyk P; Milanowski J; Małecka-Massalska T
Pathol Res Pract; 2017 Nov; 213(11):1384-1387. PubMed ID: 28964576
[TBL] [Abstract][Full Text] [Related]
4. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
[TBL] [Abstract][Full Text] [Related]
5. Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinoma.
Wang Y; Zhao H; Gao X; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X
Oncotarget; 2016 May; 7(18):26070-86. PubMed ID: 27036025
[TBL] [Abstract][Full Text] [Related]
6. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
7. Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinoma.
Tai MC; Yanagisawa K; Nakatochi M; Hotta N; Hosono Y; Kawaguchi K; Naito M; Taniguchi H; Wakai K; Yokoi K; Takahashi T
Sci Rep; 2016 Aug; 6():31389. PubMed ID: 27507195
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
9. Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma.
Sun Y; Mei H; Xu C; Tang H; Wei W
Pathol Res Pract; 2018 Jan; 214(1):119-125. PubMed ID: 29103767
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Circulatory miRNA-21 as an Efficient Non-Invasive Biomarker for the Screening of Lung Cancer Patients.
Abu-Duhier FM; Javid J; Sughayer MA; Mir R; Albalawi T; Alauddin MS
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2607-2611. PubMed ID: 30256067
[TBL] [Abstract][Full Text] [Related]
12. Differentially Expressed miRNAs in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma.
Tian F; Li R; Chen Z; Shen Y; Lu J; Xie X; Ge Q
Biomed Res Int; 2016; 2016():1428271. PubMed ID: 27247934
[TBL] [Abstract][Full Text] [Related]
13. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
[TBL] [Abstract][Full Text] [Related]
14. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
[TBL] [Abstract][Full Text] [Related]
15. Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients.
Gao F; Chang J; Wang H; Zhang G
Oncol Rep; 2014 Jan; 31(1):351-7. PubMed ID: 24190459
[TBL] [Abstract][Full Text] [Related]
16. [Molecular-genetic markers in lung cancer diagnostics].
Ponomareva AA; Rykova EIu; Cherdyntseva NV; Choĭnzonov EL; Laktionov PP; Vlasov VV
Mol Biol (Mosk); 2011; 45(2):203-17. PubMed ID: 21634110
[TBL] [Abstract][Full Text] [Related]
17. Comparative Expression of Apoptotic Markers in Lung Adenocarcinoma and Squamous Cell Carcinoma.
Porębska I; Kosacka M; Sobańska E; Wyrodek E; Jankowska R
Adv Exp Med Biol; 2015; 873():101-7. PubMed ID: 26022894
[TBL] [Abstract][Full Text] [Related]
18. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
19. Application of plasma circulating microRNA-448, 506, 4316, and 4478 analysis for non-invasive diagnosis of lung cancer.
Powrózek T; Krawczyk P; Kowalski DM; Kuźnar-Kamińska B; Winiarczyk K; Olszyna-Serementa M; Batura-Gabryel H; Milanowski J
Tumour Biol; 2016 Feb; 37(2):2049-55. PubMed ID: 26341493
[TBL] [Abstract][Full Text] [Related]
20. MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment.
Xu X; Yu S; Sun W; Qin X; Chen Y; Zhou L; Lou R; Dong S; Shen B; Wu J; Zang J; Cao H; Shi M; Zhang Q; Feng J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):431-438. PubMed ID: 29288364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
